NUTEX Investments (BUD:NUTEX) Enterprise Value: Ft-3,631.20 Mil (As of Jul. 03, 2026) ***


BUD:NUTEX NUTEX Investments PLC BUD:NUTEX
50 GF Score
Price Ft13.40
GF Value Ft13.80
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is NUTEX Investments Enterprise Value?

NUTEX Investments BUD:NUTEX -0.37% 50 Enterprise Value is Ft-3,631.20 Mil as of Jul. 03, 2026. GuruFocus rates BUD:NUTEX with a GF Score™ of 50/100 and a GF Value™ of Ft13.80 (Fairly Valued). The stock has 3 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, NUTEX Investments's Enterprise Value is Ft-3,631.20 Mil. NUTEX Investments's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was Ft-108.44 Mil. Therefore, NUTEX Investments's EV-to-EBIT ratio for today is 33.49.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, NUTEX Investments's Enterprise Value is Ft-3,631.20 Mil. NUTEX Investments's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was Ft-108.13 Mil. Therefore, NUTEX Investments's EV-to-EBITDA ratio for today is 33.58.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, NUTEX Investments's Enterprise Value is Ft-3,631.20 Mil. NUTEX Investments's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was Ft0.45 Mil. Therefore, NUTEX Investments's EV-to-Revenue ratio for today is -8,069.34.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, NUTEX Investments's Enterprise Value is Ft-3,631.20 Mil. NUTEX Investments's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was Ft256.33 Mil. Therefore, NUTEX Investments's EV-to-OCF ratio for today is -14.17.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, NUTEX Investments's Enterprise Value is Ft-3,631.20 Mil. NUTEX Investments's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was Ft255.92 Mil. Therefore, NUTEX Investments's EV-to-FCF ratio for today is -14.19.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


NUTEX Investments  (BUD:NUTEX) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

NUTEX Investments's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-3631.204/-108.44
=33.49

NUTEX Investments's current Enterprise Value is Ft-3,631.20 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was Ft-108.44 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

NUTEX Investments's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=-3631.204/-108.125
=33.58

NUTEX Investments's current Enterprise Value is Ft-3,631.20 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was Ft-108.13 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

NUTEX Investments's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-3631.204/0.45
=-8,069.34

NUTEX Investments's current Enterprise Value is Ft-3,631.20 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was Ft0.45 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

NUTEX Investments's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=-3631.204/256.33
=-14.17

NUTEX Investments's current Enterprise Value is Ft-3,631.20 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was Ft256.33 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

NUTEX Investments's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-3631.204/255.923
=-14.19

NUTEX Investments's current Enterprise Value is Ft-3,631.20 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. NUTEX Investments's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was Ft255.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NUTEX Investments Enterprise Value Related Terms


NUTEX Investments Enterprise Value Historical Data

* Premium members only.

The historical data trend for NUTEX Investments's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NUTEX Investments Enterprise Value Chart

NUTEX Investments Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,140.21 -2,188.79 -2,016.55 -1,936.75 -3,553.13

NUTEX Investments Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,016.55 -2,947.78 -1,936.75 -1,845.97 -3,553.13

BUD:NUTEX vs ZTS, UTHR, VTRS: Enterprise Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NUTEX Investments Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's Enterprise Value distribution charts can be found below:

* The bar in red indicates where NUTEX Investments's Enterprise Value falls into.


BUD:NUTEX
50GF Score
NUTEX Investments PLC BUD:NUTEX
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NUTEX Investments Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

NUTEX Investments's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

NUTEX Investments's Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of Ft-3,631.20 Mil mean?
NUTEX Investments (BUD:NUTEX) has a Enterprise Value of Ft-3,631.20 Mil as of Jul. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on NUTEX Investments and its competitors.
Is NUTEX Investments' Enterprise Value too high?
NUTEX Investments' current Enterprise Value is Ft-3,631.20 Mil. Overall, NUTEX Investments has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NUTEX Investments' Enterprise Value compare to ZTS and UTHR?
NUTEX Investments' Enterprise Value of Ft-3,631.20 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on NUTEX Investments and its competitors. NUTEX Investments's current Enterprise Value is Ft-3,631.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NUTEX Investments stock overvalued right now?
Based on GuruFocus' analysis, NUTEX Investments (BUD:NUTEX) is currently considered Fairly Valued. The stock's GF Value™ is Ft13.80, compared to a current price of Ft13.40 — trading 2.9% below its estimated fair value. The current Enterprise Value is Ft-3,631.20 Mil. NUTEX Investments' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For NUTEX Investments (BUD:NUTEX), the current Enterprise Value is Ft-3,631.20 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NUTEX Investments (BUD:NUTEX) Overvalued in 2026?

Based on GuruFocus' analysis, NUTEX Investments stock appears to be undervalued. The current stock price of Ft13.40 is trading 2.9% below its estimated GF Value™ of Ft13.80. GuruFocus considers NUTEX Investments to be Fairly Valued.

Key valuation signals for BUD:NUTEX:

  • Enterprise Value: Ft-3,631.20 Mil
  • GF Value™: Ft13.80 vs. price of Ft13.40 (2.9% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the BUD:NUTEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NUTEX Investments Business Description

Address Telepes u. 53., Budapest, HUN, 1147
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.
50GF Score

Get the complete analysis for BUD:NUTEX

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft13.40
Price
Ft13.80
GF Value